Rong Lu

3.3k total citations
105 papers, 2.7k citations indexed

About

Rong Lu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Rong Lu has authored 105 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 33 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Rong Lu's work include Peptidase Inhibition and Analysis (18 papers), Ubiquitin and proteasome pathways (9 papers) and RNA modifications and cancer (8 papers). Rong Lu is often cited by papers focused on Peptidase Inhibition and Analysis (18 papers), Ubiquitin and proteasome pathways (9 papers) and RNA modifications and cancer (8 papers). Rong Lu collaborates with scholars based in China, United States and Czechia. Rong Lu's co-authors include Jing‐Yuan Fang, Zhi Yao, Hua Xiong, Yingxuan Chen, Yuchen Wang, Yanjie Zhang, Qin Yu, Zhigang Zhang, Zhifeng Zhu and Wan Du and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Rong Lu

103 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rong Lu China	29	1.4k	667	505	340	223	105	2.7k
Hua Xie China	32	2.3k 1.6×	708 1.1×	530 1.0×	261 0.8×	179 0.8×	212	3.8k
Surajit Pathak India	32	1.7k 1.2×	781 1.2×	800 1.6×	287 0.8×	263 1.2×	177	4.0k
Nianzeng Xing China	27	1.1k 0.8×	489 0.7×	518 1.0×	445 1.3×	382 1.7×	164	3.1k
Cosmo Rossi Italy	31	1.5k 1.1×	741 1.1×	345 0.7×	177 0.5×	186 0.8×	70	3.2k
Haiyu Zhang China	30	1.5k 1.1×	399 0.6×	506 1.0×	212 0.6×	158 0.7×	90	2.9k
See‐Hyoung Park South Korea	30	1.4k 1.0×	463 0.7×	300 0.6×	245 0.7×	131 0.6×	147	2.7k
Johnny Tang Hong Kong	35	2.0k 1.4×	521 0.8×	461 0.9×	314 0.9×	212 1.0×	128	4.4k
Shengtao Yuan China	33	2.0k 1.4×	675 1.0×	1.1k 2.1×	472 1.4×	221 1.0×	116	3.5k
Bo Ma China	32	1.8k 1.3×	755 1.1×	408 0.8×	167 0.5×	297 1.3×	119	3.5k
Yajun Duan China	32	1.5k 1.1×	342 0.5×	531 1.1×	508 1.5×	137 0.6×	166	3.5k

Countries citing papers authored by Rong Lu

Since Specialization

Citations

This map shows the geographic impact of Rong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Lu more than expected).

Fields of papers citing papers by Rong Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Lu. The network helps show where Rong Lu may publish in the future.

Co-authorship network of co-authors of Rong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Rong Lu. A scholar is included among the top collaborators of Rong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong Lu. Rong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Jingdi, et al.. (2021). Effective removal of Cu 2 + from aqueous solution by synthetic abalone shell hydroxyapatite microspheres adsorbent. Environmental Technology & Innovation. 23. 101663–101663. 14 indexed citations

Lu, Xiaofang, Yong Wang, Dong Huang, et al.. (2021). YAP1 induces marrow derived suppressor cell recruitment in Chlamydia trachomatis infection. Immunology Letters. 242. 8–16. 1 indexed citations

Chen, Meng, et al.. (2021). The Study of Ginger-Derived Extracellular Vesicles as a Natural Nanoscale Drug Carrier and Their Intestinal Absorption in Rats. AAPS PharmSciTech. 22(6). 206–206. 57 indexed citations

Zhang, Chenrui, Jin‐Ping Li, Jing Jia, et al.. (2020). APN-mediated phosphorylation of BCKDK promotes hepatocellular carcinoma metastasis and proliferation via the ERK signaling pathway. Cell Death and Disease. 11(5). 396–396. 33 indexed citations

Singh, Rashim, Rong Lu, & Ming Hu. (2020). Flavonoids interference in common protein assays: Effect of position and degree of hydroxyl substitution. Analytical Biochemistry. 597. 113644–113644. 6 indexed citations

Wang, Fuyan, Lei Zhang, Xiaofang Lu, et al.. (2019). Inflammatory mechanism of Chlamydia trachomatis-infected HeLa229 cells regulated by Atg5. Biochemical and Biophysical Research Communications. 520(1). 205–210. 5 indexed citations

Zhang, Yu, et al.. (2017). The long non-coding RNA MALAT1 interacted with miR-218 modulates choriocarcinoma growth by targeting Fbxw8. Biomedicine & Pharmacotherapy. 97. 543–550. 37 indexed citations

Lu, Rong, et al.. (2014). MicroRNA-218 inhibits the proliferation of human choriocarcinoma JEG-3 cell line by targeting Fbxw8. Biochemical and Biophysical Research Communications. 450(4). 1241–1246. 15 indexed citations

Yin, Xu, et al.. (2014). Angiopoietins Promote Ovarian Cancer Progression by Establishing a Procancer Microenvironment. American Journal Of Pathology. 184(8). 2285–2296. 41 indexed citations

10.

Fu, Zheng, Li Ren, Huiting Wei, et al.. (2013). Effects of Tyroserleutide on phosphatidylinositol 3′-kinase/AKT pathway in human hepatocellular carcinoma cell. Journal of drug targeting. 22(2). 146–155. 13 indexed citations

11.

Zhu, Jing, et al.. (2011). Construction of RNAi lentiviral vector targeting mouse Islet-1 gene. Jiefangjun yixue zazhi. 36(2). 170–173. 1 indexed citations

12.

Wang, Hui, et al.. (2010). Angiopoietin-4 Promotes Glioblastoma Progression by Enhancing Tumor Cell Viability and Angiogenesis. Cancer Research. 70(18). 7283–7293. 55 indexed citations

13.

Lv, Junqiang, Wen Zhang, Song Wang, et al.. (2010). The pentapeptide PLNPK inhibits systemic lupus erythematosus-associated renal damage. Inflammation Research. 59(12). 1081–1089. 2 indexed citations

14.

Wang, Chong, Song Wang, Rong Lu, et al.. (2009). Effects of a novel tripeptide, tyroserleutide (YSL), on cell cycle progression of human hepatocellular carcinoma. Anti-Cancer Drugs. 20(7). 534–542. 2 indexed citations

15.

Zhu, Zhifeng, Lijuan Chen, Rong Lu, et al.. (2008). Tripeptide tyroserleutide plus doxorubicin: therapeutic synergy and side effect attenuation. BMC Cancer. 8(1). 342–342. 10 indexed citations

16.

He, Zhonggui, Jin Sun, Xin Wu, et al.. (2008). Profiling Drug Membrane Permeability and Activity Via Biopartitioning Chromatography. Current Drug Metabolism. 9(2). 152–166. 17 indexed citations

17.

Lu, Rong, et al.. (2007). Inhibition of the Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway Decreases DNA Methylation in Colon Cancer Cells. Journal of Biological Chemistry. 282(16). 12249–12259. 94 indexed citations

18.

Lu, Rong, et al.. (2006). A practical approach to optimization and validation of a HPLC assay for analysis of polyribosyl-ribitol phosphate in complex combination vaccines. Journal of Chromatography B. 832(2). 208–215. 8 indexed citations

19.

Lu, Rong, et al.. (2005). Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1. Cancer Letters. 233(1). 124–130. 23 indexed citations

20.

Jia, Jing, et al.. (2005). Preliminary investigation of the inhibitory effects of the tyroservaltide (YSV) tripeptide on human hepatocarcinoma BEL-7402. Cancer Biology & Therapy. 4(9). 993–997. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact